Contribution of Biosciend Industry to the Wisconsin Economy

July 13, 2011

BioForward is pleased to share with you “The Contribution of the Bioscience Industry to the Wisconsin Economy,” a comprehensive analysis of the significant economic impact the bioscience industry has on Wisconsin. Indeed, the report shows that the bioscience industry is paying high wages, creating jobs and putting Wisconsin in a stronger position to transform its […]

Read More


Getting it right on biosimilars and patient safety

July 11, 2011

By John Horton, President of LegitScript Oregon Statesman Journal In just the first three days of summer, at least six unrelated pharmaceutical manufacturers you’ve probably never heard of — companies with names like Xcellerex, Avesthagen, NeuClone and Lupin — were the subject of various press releases. The content varied, but all of the news involved […]

Read More


Patient Safety Depends on Prevention

June 29, 2011

By Andrew R. Spiegel CEO, Colon Cancer Alliance MedCity News Prevention is a key message of the Colon Cancer Alliance. Over 80% of all cases of colorectal cancer can be prevented with recommended screenings. Despite its high incidence, colorectal cancer is one of the most detectable and, if found early enough, most treatable forms of […]

Read More


Washington State Medical Society – WSMA Reports – May/June 2011 – Biosimilars and the Cost-safety Balance

June 23, 2011

Less expensive, follow-on biologics are expected to be a boon to patients and Washington’s biotechnology industry. But as the FDA implements a new approval pathway for these complicated drugs, the medical community wants to ensure patient safety comes first. Read More

Read More


European Medicines Agency and US Food and Drug Administration set up biosimilar ‘cluster’ and publish first report on interactions

June 23, 2011

The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have set up a new ‘cluster’ on biosimilar medicines.  Clusters are topic areas of mutual interest for the two agencies, which they have identified as benefiting from the regular exchange of information and collaborative meetings. Biosimilar medicines is the latest addition […]

Read More


Governor’s Life Sciences Summit & Annual Meeting

June 21, 2011

November 18, 2011 Seattle, WA Read More

Read More


WBBA/LSDF Open House

June 21, 2011

August 11, 2011 Seattle, WA Read More

Read More


Virginia Biotechnology Association

June 17, 2011

Event Calendar 2011 Read More

Read More


June 17, 2011

Biotechnology Institute Chesapeake Bioscience Education Foundation Northern Virginia Life Sciences Communities Virginia Bioscience Legislative Caucus Virginia Biotechnology Association Virginia Biotechnology Center Virginia Council on Advanced Technology Skills Virginia Department of Health Virginia General Assembly Virginia Tech Department of Biological Sciences Virginia Tech Fralin Life Science Institute Medical Society of Virginia Office of Governor Bob McDonnell […]

Read More


BIO International Convention

June 17, 2011

June 27-30, 2011 Walter E. Washington Convention Center Washington, D.C. Read More

Read More